Dodangeh F, Sadeghi Z, Maleki P, Raheb J
Sci Rep. 2023; 13(1):12371.
PMID: 37524903
PMC: 10390639.
DOI: 10.1038/s41598-023-39000-0.
Maleki P, Mowla S, Taheri M, Ghafouri-Fard S, Raheb J
Sci Rep. 2021; 11(1):4210.
PMID: 33602983
PMC: 7892821.
DOI: 10.1038/s41598-021-82892-z.
Yu C, Gong Y, Zhou H, Wang M, Kong L, Liu J
Cell Death Dis. 2017; 8(2):e2582.
PMID: 28151486
PMC: 5386448.
DOI: 10.1038/cddis.2016.199.
Guo W, Zhang Y, Ling Z, Liu X, Zhao X, Yuan Z
Cell Death Dis. 2015; 6:e1919.
PMID: 26469967
PMC: 4632302.
DOI: 10.1038/cddis.2015.276.
Adjeroh D, Jiang Y, Jiang B, Lin J
Cancer Inform. 2015; 13(Suppl 5):109-24.
PMID: 25741177
PMC: 4338801.
DOI: 10.4137/CIN.S14059.
Pronounced transcriptional regulation of apoptotic and TNF-NF-kappa-B signaling genes during the course of thymoquinone mediated apoptosis in HeLa cells.
Sakalar C, Yuruk M, Kaya T, Aytekin M, Kuk S, Canatan H
Mol Cell Biochem. 2013; 383(1-2):243-51.
PMID: 23943306
DOI: 10.1007/s11010-013-1772-x.
p14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins.
Muer A, Overkamp T, Gillissen B, Richter A, Pretzsch T, Milojkovic A
J Biol Chem. 2012; 287(21):17343-17352.
PMID: 22354970
PMC: 3366797.
DOI: 10.1074/jbc.M111.314898.
Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak.
Wang C, Youle R
Oncogene. 2011; 31(26):3177-89.
PMID: 22056880
PMC: 3276724.
DOI: 10.1038/onc.2011.497.
Killing of resistant cancer cells with low Bak by a combination of an antimesothelin immunotoxin and a TRAIL Receptor 2 agonist antibody.
Du X, Xiang L, Mackall C, Pastan I
Clin Cancer Res. 2011; 17(18):5926-34.
PMID: 21813632
PMC: 3177016.
DOI: 10.1158/1078-0432.CCR-11-1235.
Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.
Gillissen B, Wendt J, Richter A, Richter A, Muer A, Overkamp T
J Cell Biol. 2010; 188(6):851-62.
PMID: 20308427
PMC: 2845080.
DOI: 10.1083/jcb.200912070.
BAX/BAK-independent mitoptosis during cell death induced by proteasome inhibition?.
Lomonosova E, Ryerse J, Chinnadurai G
Mol Cancer Res. 2009; 7(8):1268-84.
PMID: 19671675
PMC: 2927846.
DOI: 10.1158/1541-7786.MCR-08-0183.
BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes.
Chinnadurai G, Vijayalingam S, Rashmi R
Oncogene. 2009; 27 Suppl 1:S20-9.
PMID: 19641504
PMC: 2928562.
DOI: 10.1038/onc.2009.40.
Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery alone.
Nehls O, Hass H, Okech T, Zenner S, Hsieh C, Sarbia M
Int J Colorectal Dis. 2009; 24(6):655-63.
PMID: 19221769
DOI: 10.1007/s00384-009-0635-0.
UVB upregulates the bax promoter in immortalized human keratinocytes via ROS induction of Id3.
Trabosh V, Daher A, DiVito K, Amin K, Simbulan-Rosenthal C, Rosenthal D
Exp Dermatol. 2008; 18(4):387-95.
PMID: 19054058
PMC: 2759318.
DOI: 10.1111/j.1600-0625.2008.00801.x.
Enhanced micronucleus formation and modulation of BCL-2:BAX in MCF-7 cells after exposure to binary mixtures.
Hewitt R, Forero A, Luncsford P, Martin F
Environ Health Perspect. 2008; 115 Suppl 1:129-36.
PMID: 18174961
PMC: 2174410.
DOI: 10.1289/ehp.9361.
Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis.
Gillissen B, Essmann F, Hemmati P, Richter A, Richter A, Oztop I
J Cell Biol. 2007; 179(4):701-15.
PMID: 18025305
PMC: 2080900.
DOI: 10.1083/jcb.200703040.
BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells.
Rashmi R, Pillai S, Vijayalingam S, Ryerse J, Chinnadurai G
Oncogene. 2007; 27(10):1366-75.
PMID: 17873911
PMC: 2928058.
DOI: 10.1038/sj.onc.1210783.
Gene expression profiling reveals two separate mechanisms regulating apoptosis in rectal carcinomas in vivo.
de Bruin E, van de Pas S, van de Velde C, van Krieken J, Peltenburg L, Marijnen C
Apoptosis. 2007; 12(9):1671-80.
PMID: 17610066
PMC: 2668623.
DOI: 10.1007/s10495-007-0088-2.
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX.
Nehls O, Okech T, Hsieh C, Enzinger T, Sarbia M, Borchard F
Br J Cancer. 2007; 96(9):1409-18.
PMID: 17426704
PMC: 2360187.
DOI: 10.1038/sj.bjc.6603728.
MAP-1 is a mitochondrial effector of Bax.
Tan K, Fu N, Sukumaran S, Chan S, Kang J, Poon K
Proc Natl Acad Sci U S A. 2005; 102(41):14623-8.
PMID: 16199525
PMC: 1239892.
DOI: 10.1073/pnas.0503524102.